BackFirst Tracks Biotherapeutics Overview

First Tracks Biotherapeutics Other Current Liabilities

First Tracks Biotherapeutics's other current liabilities is $7.5M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$7.46M

Peer trimmed avg / median

Loading

First Tracks Biotherapeutics Other Current Liabilities History

Loading

First Tracks Biotherapeutics vs. peers: Other Current Liabilities Comparison

Loading

First Tracks Biotherapeutics Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

First Tracks Biotherapeutics (TRAX) FAQ

As of the most recent data (June 2026), TRAX shows a other current liabilities of $7.5M. Scroll down for historical charts and peer comparison views.

Tracking TRAX's other current liabilities over time shows whether First Tracks Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $7.5M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has First Tracks Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $7.5M) with ownership activity and broader fundamentals.

First Tracks Biotherapeutics's other current liabilities is $7.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.